Vascular Biology |
From the Departments of Internal Medicine and Pharmacology, The Cardiovascular Center, The University of Iowa, and Veterans Administration Medical Center, Iowa City, Iowa.
Correspondence to Kathryn G. Lamping, PhD, Medical Services (111), VA Medical Center, 601 Highway 6 West, Iowa City, IA 52246. E-mail kathryn-lamping{at}uiowa.edu
AbstractWe
examined the hypothesis that contraction of the carotid arteries to
serotonin is normally inhibited by
endothelial NO synthase (eNOS) and is enhanced in mice
lacking the gene for eNOS. Because the influence of eNOS may vary with
the sex of the mouse, we also tested whether responses to
serotonin were dependent on sex. We studied carotid
arteries in vitro from littermate control
(eNOS+/+) mice, heterozygous
(eNOS+/-) mice, and homozygous
eNOS-deficient (eNOS-/-) mice (male and
female). Contraction to serotonin was greater in male
eNOS+/+ mice than in female
eNOS+/+ mice. In male mice, contraction to
serotonin increased by
40% and 2.5-fold in male
eNOS+/- and
eNOS-/- mice, respectively. Contraction
to serotonin was more than doubled in female
eNOS+/- mice and increased >5-fold in
arteries from eNOS-/- mice. In contrast,
maximum vasoconstriction to U46619 was similar in male and female
eNOS+/+,
eNOS+/-, and
eNOS-/- mice. Relaxation to
acetylcholine was not different in male and female
eNOS+/+ or
eNOS+/- mice but was absent in
eNOS-/- mice. These findings suggest
that the contraction of carotid arteries to serotonin is
influenced by the sex of the animal. eNOS deficiency in gene-targeted
mice is associated with enhanced contraction to serotonin,
particularly in female mice, providing direct evidence that eNOS is a
major determinant of vascular effects of serotonin. The
results with eNOS+/- mice suggest a
"gene-dosing" effect for vascular responses to
serotonin.
Key Words: NO synthase acetylcholine thromboxane mice genetically altered mice
This article has been cited by other articles:
![]() |
D. W. Nuno, J. S. Harrod, and K. G. Lamping Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1469 - H1477. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Brosnihan, P. Li, J. P. Figueroa, D. Ganten, and C. M. Ferrario Estrogen, nitric oxide, and hypertension differentially modulate agonist-induced contractile responses in female transgenic (mRen2)27 hypertensive rats Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H1995 - H2001. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Beyer, G. L. Baumbach, C. M. Halabi, M. L. Modrick, C. M. Lynch, T. D. Gerhold, S. M. Ghoneim, W. J. de Lange, H. L. Keen, Y.-S. Tsai, et al. Interference With PPAR{gamma} Signaling Causes Cerebral Vascular Dysfunction, Hypertrophy, and Remodeling Hypertension, April 1, 2008; 51(4): 867 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Nuno, V. P. Korovkina, S. K. England, and K. G. Lamping RhoA Activation Contributes to Sex Differences in Vascular Contractions Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1934 - 1940. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Didion, D. A. Kinzenbaw, L. I. Schrader, and F. M. Faraci Heterozygous CuZn Superoxide Dismutase Deficiency Produces a Vascular Phenotype With Aging Hypertension, December 1, 2006; 48(6): 1072 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-D. Chen and A. F. Chen CuZn Superoxide Dismutase Deficiency: Culprit of Accelerated Vascular Aging Process Hypertension, December 1, 2006; 48(6): 1026 - 1028. [Full Text] [PDF] |
||||
![]() |
F. M. Faraci Protecting the Brain With eNOS: Run for Your Life Circ. Res., November 10, 2006; 99(10): 1029 - 1030. [Full Text] [PDF] |
||||
![]() |
S. P. Didion and F. M. Faraci Ceramide-Induced Impairment of Endothelial Function Is Prevented by CuZn Superoxide Dismutase Overexpression Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 90 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Faraci, C. Lynch, and K. G. Lamping Responses of cerebral arterioles to ADP: eNOS-dependent and eNOS-independent mechanisms Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2871 - H2876. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Baumbach, C. D. Sigmund, and F. M. Faraci Structure of Cerebral Arterioles in Mice Deficient in Expression of the Gene for Endothelial Nitric Oxide Synthase Circ. Res., October 15, 2004; 95(8): 822 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Andresen, F. M. Faraci, and D. D. Heistad Vasomotor responses in MnSOD-deficient mice Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1141 - H1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Budzyn, P. D. Marley, and C. G. Sobey Chronic mevastatin modulates receptor-dependent vascular contraction in eNOS-deficient mice Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R342 - R348. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Lamping, J. Wess, Y. Cui, D. W. Nuno, and F. M. Faraci Muscarinic (M) Receptors in Coronary Circulation: Gene-Targeted Mice Define the Role of M2 and M3 Receptors in Response to Acetylcholine Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1253 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ortiz and J. L. Garvin Cardiovascular and renal control in NOS-deficient mouse models Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R628 - R638. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Faraci Vascular Protection Stroke, February 1, 2003; 34(2): 327 - 329. [Full Text] [PDF] |
||||
![]() |
Q. Fang, H. Sun, and W. G. Mayhan Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H528 - H534. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Didion, M. J. Ryan, L. A. Didion, P. E. Fegan, C. D. Sigmund, and F. M. Faraci Increased Superoxide and Vascular Dysfunction in CuZnSOD-Deficient Mice Circ. Res., November 15, 2002; 91(10): 938 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V d'Uscio, M. Barton, S. Shaw, and T. F Luscher Chronic ETA receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice Cardiovasc Res, February 1, 2002; 53(2): 487 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Huang, Y. Wu, D. Sun, A. Koller, and G. Kaley Effect of estrogen on flow-induced dilation in NO deficiency: role of prostaglandins and EDHF J Appl Physiol, December 1, 2001; 91(6): 2561 - 2566. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |